study_id,year,design,effect_type,effect_point,ci_low,ci_high,n_treat,n_ctrl,risk_of_bias,doi,journal_id,outcome,population,adverse_events,duration_weeks
MUSC-MSK14-01,2011,randomized controlled trial,SMD,0.2282,0.1035,0.3529,91,88,mixed,10.1234/musc-msk14-01,musculoskeletal-journal-01,bone_density,Adults with bone density concerns,Mild GI discomfort,11
MUSC-MSK14-02,2016,randomized controlled trial,SMD,0.2228,0.0457,0.3999,74,72,low,10.1234/musc-msk14-02,musculoskeletal-journal-02,bone_density,Adults with bone density concerns,None reported,9
MUSC-MSK14-03,2021,randomized controlled trial,SMD,0.2174,0.0579,0.3769,87,87,low,10.1234/musc-msk14-03,musculoskeletal-journal-03,bone_density,Adults with bone density concerns,Transient headache,8
